City Center Advisors »

Aurinia Pharmaceuticals shares owned by City Center Advisors

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by City Center Advisors from 13F filings

Historical chart of City Center Advisors investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by City Center Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by City Center Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $359k 33k 11.05
2025-06-30 $222k 26k 8.47

More positions owned by City Center Advisors

Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Select Sector Spdr Tr Technology (XLK)
Select Sector Spdr Tr Indl (XLI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Comm Srvc Etf (VOX)
Ishares Tr Msci Eafe Etf (EFA)
Invesco Exchange Traded Fd T Aerospace Defn (PPA)
Ishares Tr 0-5yr Invt Gr Cp (SLQD)
Ssga Active Etf Tr Blackstone Senr (SRLN)
NVIDIA Corporation (NVDA)
Select Sector Spdr Tr Financial (XLF)

View all positions for City Center Advisors

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Vanguard Group
Geode Capital Management
Marshall Wace
Renaissance Technologies
Two Sigma Investments
Jacobs Levy Equity Management
Jane Street
Qube Research & Technologies
Henderson Group

View all funds holding Aurinia Pharmaceuticals